glp-1 therapy weight loss milestones timeline The Landscape Of Receptor Agonists In Diabetes And Obesity Treatment GLP-1R Agonists for Weight Loss

In the UK, different GLP-1 receptor agonists have specific licensed indications: For type 2 diabetes : semaglutide (Ozempic), dulaglutide (Trulicity), and liraglutide (Victoza) For weight management : semaglutide 2.4mg (Wegovy) and liraglutide 3.0mg (Saxenda) NICE guideline NG28 recommends GLP-1 receptor agonists as treatment options for type 2 diabetes when first-line therapies have not achieved adequate glycaemic control

While nutrition and lifestyle cannot produce the same powerful effects as GLP-1 medications, research shows that some foods stimulate a greater GLP-1 response than others

Those patients that have complications that have been shown to be ameliorated by GLP-1-based drugs, and I would say secondary prevention of cardio, of heart attacks for semaglutide

Copper accumulation is not a concern at therapeutic peptide doses

A new study is investigating whether higher doses of injectable GLP-1 agonist Trulicity (dulaglutide) are more effective

Acute kidney injury can result from insults within the kidney itself (renal causes), reduction of blood flow into the kidney (prerenal causes), or damage to the lower urinary tract that causes the backup of uremic toxins into the kidney (postrenal causes) (Ferri 2014a